$1.12
-0.13-10.40%
At close: -
$1.09
-0.03-2.68%
After Hours: 5:02 PM EDT
Comments
Loading...
Aptevo Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:APVO | Benzinga
Aptevo Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 8
EPS Estimate
$-10.360
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Aptevo Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| APVO | Aptevo Therapeutics | -$368.15 | -$10.36 | — | — | $0.00 | — | — | — | 05/07/2025 | Get Alert |
| APVO | Aptevo Therapeutics | -$65.12 | -$10.36 | — | — | $0.00 | — | — | — | 04/08/2025 | Get Alert |
| APVO | Aptevo Therapeutics | -$814.00 | -$123.95 | -$17.76 | 85.67% | $0.00 | — | $0.00 | — | 11/07/2024 | Get Alert |
| APVO | Aptevo Therapeutics | -$2.00K | -$145.04 | -$61.79 | 57.40% | $0.00 | — | $0.00 | — | 08/08/2024 | Get Alert |
| APVO | Aptevo Therapeutics | $423.65 | -$475.08 | -$368.15 | 22.51% | $0.00 | — | $0.00 | — | 05/08/2024 | Get Alert |
| APVO | Aptevo Therapeutics | -$2.34K | -$667.48 | -$65.12 | 90.24% | $0.00 | — | $0.00 | — | 03/05/2024 | Get Alert |
| APVO | Aptevo Therapeutics | -$2.44K | -$1.22K | -$814.00 | 33.33% | $0.00 | — | $0.00 | — | 11/14/2023 | Get Alert |
| APVO | Aptevo Therapeutics | -$2.96K | -$1.82K | -$2.00K | -9.82% | $0.00 | — | $0.00 | — | 08/10/2023 | Get Alert |
| APVO | Aptevo Therapeutics | -$2.52K | -$1.92K | -$1.60K | 16.95% | $3.11M | — | $0.00 | — | 05/11/2023 | Get Alert |
| APVO | Aptevo Therapeutics | -$2.17K | -$2.49K | -$2.34K | 5.88% | $3.67M | — | $0.00 | — | 03/30/2023 | Get Alert |
| APVO | Aptevo Therapeutics | -$2.33K | -$2.67K | -$2.44K | 8.54% | $3.10M | — | $0.00 | — | 11/10/2022 | Get Alert |
| APVO | Aptevo Therapeutics | -$2.90K | -$2.17K | -$2.96K | -36.84% | $3.11M | $3.42M | $0.00 | -100.00% | 08/11/2022 | Get Alert |
| APVO | Aptevo Therapeutics | -$2.67K | -$1.87K | -$2.52K | -34.78% | $2.42M | $3.75M | $3.11M | -16.96% | 05/12/2022 | Get Alert |
| APVO | Aptevo Therapeutics | -$2.88K | -$2.10K | -$2.17K | -3.10% | $2.37M | $3.40M | $3.67M | 7.79% | 03/24/2022 | Get Alert |
| APVO | Aptevo Therapeutics | -$3.50K | -$2.39K | -$2.33K | 2.72% | $1.46M | $3.65M | $3.10M | -15.18% | 11/12/2021 | Get Alert |
| APVO | Aptevo Therapeutics | -$3.42K | -$3.00K | -$2.90K | 3.26% | $473.00K | $900.00K | $3.11M | 245.56% | 08/12/2021 | Get Alert |
| APVO | Aptevo Therapeutics | -$3.92K | $2.75K | -$2.83K | -202.96% | $0.00 | $2.42M | $2.42M | 0.04% | 05/11/2021 | Get Alert |
| APVO | Aptevo Therapeutics | -$4.33K | -$2.15K | -$2.88K | -34.09% | $9.03M | $2.16M | $2.37M | 9.86% | 03/31/2021 | Get Alert |
| APVO | Aptevo Therapeutics | -$5.24K | — | -$3.50K | — | $9.01M | — | $1.46M | — | 11/10/2020 | Get Alert |
| APVO | Aptevo Therapeutics | -$6.84K | — | -$3.42K | — | $7.36M | — | $473.00K | — | 08/14/2020 | Get Alert |
| APVO | Aptevo Therapeutics | -$10.03K | — | -$3.92K | — | $7.02M | — | $0.00 | — | 05/13/2020 | Get Alert |
Aptevo Therapeutics (APVO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-07 | $-17.76 | $-123.95 | 85.7 % |
| Q2 | 2024-08-08 | $-61.79 | $-145.04 | 57.4 % |
| Q1 | 2024-05-08 | $-368.15 | $-475.08 | 22.5 % |
| Q4 | 2024-03-05 | $-65.12 | $-667.48 | 90.2 % |
Aptevo Therapeutics (APVO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | 2022-08-11 | $0 | $3.42M | -100.0 % |
| Q1 | 2022-05-12 | $3.11M | $3.75M | -17.0 % |
| Q4 | 2022-03-24 | $3.67M | $3.40M | 7.79 % |
| Q3 | 2021-11-12 | $3.10M | $3.65M | -15.2 % |
FAQ
When is Aptevo Therapeutics (NASDAQ:APVO) reporting earnings?
Aptevo Therapeutics (APVO) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
What were the latest earnings per share (EPS) for Aptevo Therapeutics (NASDAQ:APVO)?
The Actual EPS was $-17.76, which beat the estimate of $-123.95.
What were Aptevo Therapeutics’s (NASDAQ:APVO) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.